These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9711777)
21. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants. Zangwill KM; Greenberg DP; Chiu CY; Mendelman P; Wong VK; Chang SJ; Partridge S; Ward JI Vaccine; 2003 May; 21(17-18):1894-900. PubMed ID: 12706674 [TBL] [Abstract][Full Text] [Related]
22. Progress towards meningitis prevention in the conjugate vaccines era. Laval CA; Pimenta FC; de Andrade JG; Andrade SS; de Andrade AL Braz J Infect Dis; 2003 Oct; 7(5):315-24. PubMed ID: 14552741 [TBL] [Abstract][Full Text] [Related]
23. Immune responses to polysaccharides: lessons from humans and mice. González-Fernández A; Faro J; Fernández C Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186 [TBL] [Abstract][Full Text] [Related]
24. Use of bacterial vaccines for prevention of pneumococcal and meningococcal disease in the day care setting. Broome CV Rev Infect Dis; 1986; 8(4):584-8. PubMed ID: 3092300 [TBL] [Abstract][Full Text] [Related]
25. Bacterial meningitis: the impact of vaccination. Makwana N; Riordan FA CNS Drugs; 2007; 21(5):355-66. PubMed ID: 17447825 [TBL] [Abstract][Full Text] [Related]
26. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996 [TBL] [Abstract][Full Text] [Related]
27. MenHibrix: a new combination meningococcal vaccine for infants and toddlers. Hale SF; Camaione L; Lomaestro BM Ann Pharmacother; 2014 Mar; 48(3):404-11. PubMed ID: 24353263 [TBL] [Abstract][Full Text] [Related]
28. Prevention of Haemophilus influenzae type b disease. Santosham M Vaccine; 1993; 11 Suppl 1():S52-7. PubMed ID: 8447177 [TBL] [Abstract][Full Text] [Related]
29. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481 [TBL] [Abstract][Full Text] [Related]
30. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282 [TBL] [Abstract][Full Text] [Related]
31. Vaccines against polysaccharide antigens. Lesinski GB; Westerink MA Curr Drug Targets Infect Disord; 2001 Nov; 1(3):325-34. PubMed ID: 12455405 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. Walter EB; Moggio MV; Drucker RP; Wilfert CM Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187 [TBL] [Abstract][Full Text] [Related]
33. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines. Siber GR; Anderson R; Habafy M; Gupta RK Vaccine; 1995 Apr; 13(6):525-31. PubMed ID: 7483772 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. Buttery JP; Riddell A; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Harnden A; Lockhart S; Pollard AJ; Cartwright K; Moxon ER JAMA; 2005 Apr; 293(14):1751-8. PubMed ID: 15827314 [TBL] [Abstract][Full Text] [Related]
35. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. Kurikka S; Käyhty H; Saarinen L; Rönnberg PR; Eskola J; Mäkelä PH J Infect Dis; 1995 Nov; 172(5):1268-72. PubMed ID: 7594663 [TBL] [Abstract][Full Text] [Related]
36. The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials. Voysey M; Sadarangani M; Clutterbuck E; Bolgiano B; Pollard AJ Vaccine; 2016 Jul; 34(34):3986-92. PubMed ID: 27349840 [TBL] [Abstract][Full Text] [Related]
37. Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. Lagos R; Munoz A; Levine MM; Watson W; Chang I; Paradiso P Vaccine; 2009 Apr; 27(17):2299-305. PubMed ID: 19428843 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. Barra A; Cordonnier C; Preziosi MP; Intrator L; Hessel L; Fritzell B; Preud'homme JL J Infect Dis; 1992 Nov; 166(5):1021-8. PubMed ID: 1402013 [TBL] [Abstract][Full Text] [Related]
39. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. Latz E; Franko J; Golenbock DT; Schreiber JR J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714 [TBL] [Abstract][Full Text] [Related]